Concepedia

Susan L. Rosenkranz

SL

Statistics

Publications

41

Citations

2.7K

H-Index

24

Active since

1997

Affiliations

Harvard University(Current)

Frontier Science & Technology Research Foundation, Inc.

Johns Hopkins University

University of California, San Francisco

National Institute of Allergy and Infectious Diseases

Susan L. Rosenkranz is an author at Harvard University specializing in antiretroviral therapy, pharmacy, and pharmacology.

Publications per year

1997–2024

41

Publications

41

The practice orientations of physicians and patients: the effect of doctor–patient congruence on satisfaction

Edward Krupat, Susan L. Rosenkranz, Carter M. Yeager et al. · Patient Education and Counseling · 2000 · 469 citations

, , +10

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047

Carl J. Fichtenbaum, John G. Gerber, Susan L. Rosenkranz et al. · AIDS · 2002 · 339 citations

, , +16

Effect of Efavirenz on the Pharmacokinetics of Simvastatin, Atorvastatin, and Pravastatin

John G. Gerber, Susan L. Rosenkranz, Carl J. Fichtenbaum et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 166 citations

, , +15

The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)

Thomas P. Lodise, Susan L. Rosenkranz, Matthew Finnemeyer et al. · Clinical Infectious Diseases · 2019 · 160 citations · Full text

, , +17

Population Pharmacokinetics and Pharmacodynamics of Efavirenz, Nelfinavir, and Indinavir: Adult AIDS Clinical Trial Group Study 398

Marc Pfister, Line Labbé, Scott M. Hammer et al. · Antimicrobial Agents and Chemotherapy · 2002 · 129 citations

, , +17

1–5 of 41